Skip to main content Skip to section navigation Skip to footer
Careers Search
Grace Therapeutics, Inc. Homepage
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • GTx-104
    • Overview
    • STRIVE-ON Trial
    • Publications
  • Our Pipeline
  • Newsroom
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Results
    • Stock Data
    • SEC Filings
    • Governance
  • Contact Us
  • Careers
  • Search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Company Profile
    • Presentations
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • Quote and Chart
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
    • Tax Notifications
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Events
  • Email Alerts
Jun 22, 2022 6:10 pm EDT
Acasti Pharma Announces Annual Grants of Performance Stock Options
Jun 21, 2022 8:00 am EDT
Acasti Pharma Reports Fiscal Year 2022 Operational Results
Jun 16, 2022 4:15 pm EDT
Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call
Jun 14, 2022 8:00 am EDT
Acasti Pharma Announces the Issuance of Additional Patents for GTX-104 and GTX-101
May 23, 2022 4:15 pm EDT
Acasti Pharma Inc. Retains Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program
May 18, 2022 7:30 am EDT
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints
May 16, 2022 1:30 pm EDT
Acasti Pharma CEO to Present at Microcap Rodeo’s Spring into Action Best Ideas Virtual Conference on May 18th
Apr 25, 2022 8:30 am EDT
Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th
Mar 25, 2022 7:30 am EDT
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors
Mar 22, 2022 7:30 am EDT
Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan
  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • …
  • Page 29
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
©2025 Grace Therapeutics, Inc. All Rights Reserved.
  • Privacy Policy
  • Disclaimer
  • Sitemap
  • Accessibility Statement
  • Manage Cookie Preferences